Table 4.
Results of survival analysis
| n | Median RFS (mo) | 95%CI of HR | Median DRS (mo) | 95%CI of HR | Median Gold’s point (range) | Predicted 2-year RFS probability | Actual 2-year RFS rate | Predicted 5-year RFS probability | Actual 5-year RFS rate | |
| Total | 25 | 60.5 | - | 73 | - | 73 (50-190) | 83% | 83.30% | 70% | 50% |
| Fletcher’s risk | ||||||||||
| Very low/low | 9 | 103ce | 1.564-158.6 | Undefined | 0.6931-149.1 | 64 (50-70)df | 86% | 100% | 75% | 100% |
| Intermediate | 5 | 53 | 0.7675-7.845 | Undefined | 0.9385-10.78 | 71 (71-81)bf | 84% | 100% | 70% | 40% |
| High | 11 | 29bd | 4.812-68.51 | 40bd | 3.449-44.94 | 173 (155-190)bd | < 10% | 70% | < 10% | < 10% |
| Miettinen's risk | ||||||||||
| Low | 9 | 103f | 2.882-26.67 | Undefined | 2.224-21.94 | 64 (50-70)f | 86% | 100% | 75% | 100% |
| High | 16 | 47b | - | 56 | - | 160 (71-190)b | < 10% | 80% | < 10% | 20% |
aP < 0.05,
P < 0.01 vs Very low/Low;
P < 0.05,
P < 0.01 vs Intermediate;
P < 0.05,
P < 0.01 vs High; DRS: Disease-related survival; RFS: Relapse-free survival.